Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database

Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database

Abstract Background Immune checkpoint inhibitors (ICIs) are medications used in cancer immunotherapy. However, treatment with ICIs may lead to adverse effects, particularly myocarditis and pericarditis. This practical pharmacovigilance study investigates the relationship between ICIs and myocarditis...

Full description

Saved in:
Bibliographic Details
Main Authors: Guojing Yao, Yu Zhang, Haixia Zhang, Linlin Tang, Chuanhua Ding, Xueheng Zhou
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Cancer
Subjects:
Immune checkpoint inhibitors (ICIs)
Myocarditis/pericarditis
Pharmacovigilance
FDA adverse event reporting system (FAERS)
Data mining
Online Access:https://doi.org/10.1186/s12885-025-14668-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14668-x

Similar Items